Kingdon Capital Management, L.L.C. Vincerx Pharma, Inc. Transaction History

Kingdon Capital Management, L.L.C.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$0.0 - $0.0 $0 - $0	80,104 Added 26.27%	385,000 $3.92 Million
Q3 2021 Nov 15, 2021	BUY	$0.0 - $0.0 $0 - $0	101,478 Added 49.89%	304,896 $4.93 Million
Q2 2021 Aug 16, 2021	BUY	$0.0 - $27.0 $0 - $5.49 Million	203,418 New	203,418 $2.64 Million

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $4.03M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.